Adenosine and adenosine receptors in the immunopathogenesis and treatment of cancer
Mohammad Hossein Kazemi(University of Southern California), Farhad Jadidi‐Niaragh(Tabriz University of Medical Sciences), Hamed Mohammadi(Tehran University of Medical Sciences), Ghasem Ghalamfarsa(Yasuj University of Medical Sciences), Mohammad Hojjat‐Farsangi(Karolinska University Hospital), Enayat Anvari(Medical University of Ilam), Sahar Raoofi Mohseni(Tehran University of Medical Sciences)
Cited by 150
Related Papers
Nanoparticles and targeted drug delivery in cancer therapy
|Immunology Letters|2017|507
The significant role of interleukin-6 and its signaling pathway in the immunopathogenesis and treatment of breast cancer
|Biomedicine & Pharmacotherapy|2018|312
The paradox of Th17 cell functions in tumor immunity
|Cellular Immunology|2017|222
Small-Molecule Inhibitors of the Receptor Tyrosine Kinases: Promising Tools for Targeted Cancer Therapies
|International Journal of Molecular Sciences|2014|202
A role for Th1-like Th17 cells in the pathogenesis of inflammatory and autoimmune disorders
|Molecular Immunology|2018|194